AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024
Aug 27, 2024
35599_dirs_2024-08-27_b848c35b-a191-4bbf-a080-25e6dc91f69a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-08-23
Reporting Person: Raykov Rosty (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-23 | Common shares | G | 50000 | — | Disposed | 137471 | Direct |
| 2024-08-23 | Common shares | G | 16666 | — | Disposed | 120805 | Direct |
| 2024-08-23 | Common shares | G | 28372 | — | Disposed | 92433 | Direct |
| 2024-08-23 | Common shares | G | 26001 | — | Disposed | 66432 | Direct |
Footnotes
F1: This transaction represents a donation of shares of the Issuer's Common Stock to a charity.
F2: This amendment is being filed to correct an administrative error in the Form 4 filed by Mr. Rosty that did not include 26,001 shares donated.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20